Related Experiment Video
Updated: Aug 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Patients' perspectives on statin therapy for treatment of hypercholesterolaemia: a qualitative study
Elizabeth P Tolmie1, Grace M Lindsay, Susan M Kerr
1Nursing and Midwifery School, University of Glasgow, 59 Oakfield Avenue, G12 8SW, Glasgow, Scotland, UK. e.p.tolmie@clinmed.gla.ac.uk
Insights
Patient understanding of cholesterol and communication with healthcare providers significantly influence statin therapy adherence. Addressing health beliefs and improving information exchange are crucial for improving coronary heart disease secondary prevention.
Area of Science:
- Cardiology
- Public Health
- Health Psychology
Background:
- Statin therapy non-adherence hinders coronary heart disease (CHD) secondary prevention.
- Understanding patient perspectives on statin compliance is essential.
Purpose of the Study:
- To explore patient perspectives on compliance with statin therapy.
Main Methods:
- Qualitative study involving 33 patients with varying statin compliance.
- In-depth, one-to-one interviews were conducted.
- Thematic analysis of interview data was performed.
Main Results:
- Patient-provider communication and health beliefs emerged as key factors influencing compliance.
- Themes included therapy initiation, feedback, misconceptions, and acceptance/rejection.
- Information exchange and patient beliefs about cholesterol impact adherence.
Conclusions:
- Assess patient understanding of cholesterol and treatment strategies before and during statin therapy.
- Tailor interventions to address individual health beliefs and communication needs.
Background:
Health Care Practitioners' attempts to implement secondary prevention targets for coronary heart disease (CHD) may be restricted by low rates of persistence with statin therapy. There is a need to understand why some patients, despite having established CHD and elevated cholesterol, do not comply with their prescribed statin regimen.
Aim:
To explore patients' perspectives on compliance with statin therapy.
Setting:
Primary care, West of Scotland.
Methods:
The research approach was qualitative. Thirty-three patients prescribed statin therapy and identified as having different patterns of compliance (poor moderate and good) were interviewed. The in-depth interviews were conducted on a one to one basis. Patients prescribed statin therapy for less than three months were excluded. Data were analysed thematically with the assistance of QSR Nudist.
Findings:
From analysis of the narrative data, two broad categories, i.e. 'Patient-health care provider communication' and 'Health beliefs' were identified. These categories encompassed six main themes: 'Initiation of therapy'; 'Subsequent feedback'; 'Sources of misconceptions'; 'Unconditional acceptance'; 'Conditional acceptance'; 'Deferment and Rejection'. Acceptance of and compliance with statin therapy appeared to be associated with the provision, interpretation and feedback of information during patient-practitioner consultations, and patients' beliefs about personal health status, cholesterol, and recommended cholesterol-lowering strategies.
Conclusions:
Patients' beliefs and understanding about cholesterol, and the role of cholesterol modifying strategies should be determined prior to the initiation of therapy and at appropriate intervals thereafter.
More Related Videos
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Bioavailability Study Design: Healthy Subjects Versus Patients
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management

